Wedbush Reiterates Outperform on Nuvalent, Maintains $125 Price Target

Nuvalent, Inc. Class A

Nuvalent, Inc. Class A

NUVL

0.00

Wedbush analyst David Nierengarten reiterates Nuvalent (NASDAQ: NUVL) with a Outperform and maintains $125 price target.